Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan for early treatment of acute migraine
NCT00516737Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Rizatriptan with Placebo (2 arms). Primary endpoint: Number of Participants Who Are Pain Free at 2 Hours Post-Dose. Started Oct 2007; status: completed.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00516737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516737.